Biogen Inc.

05/12/2021 | Press release | Distributed by Public on 05/12/2021 05:32

Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data